Sagerman R H, Kotlove D J, Regine W F, Chung C T, King G A, Dalal P S
Division of Radiation Oncology, State University of New York Health Science Center, Syracuse 13210.
Radiology. 1989 Aug;172(2):565-8. doi: 10.1148/radiology.172.2.2748840.
One hundred forty patients with testicular seminoma were treated at the State University of New York Health Science Center at Syracuse between 1966 and 1985. Disease was classified as stage II in 32 patients (23%): stage IIA in 21 patients and stage IIB in 11 patients. All patients underwent irradiation below the diaphragm after a radical orchiectomy, and 28 underwent planned mediastinal and supraclavicular irradiation. The median follow-up was 8 1/2 years; 24 of 32 patients have been followed up for more than 5 years. Twenty-eight patients remain alive and well; four patients died of intercurrent disease. Two patients developed a recurrent seminoma in the mediastinum; a variant lymphangiographic pattern was shown in these patients, and they were cured. A third patient developed a non-seminomatous "recurrence" in the ipsilateral, unirradiated, inguinal nodes and is well after chemotherapy.
1966年至1985年间，纽约州立大学锡拉丘兹健康科学中心收治了140例睾丸精原细胞瘤患者。32例患者（23%）疾病被分类为II期：21例为IIA期，11例为IIB期。所有患者在根治性睾丸切除术后均接受了膈下照射，28例接受了计划性纵隔和锁骨上照射。中位随访时间为8.5年；32例患者中有24例随访时间超过5年。28例患者仍存活且状况良好；4例患者死于并发疾病。2例患者纵隔出现复发性精原细胞瘤；这些患者显示出淋巴管造影的变异模式，且已治愈。第3例患者在同侧未照射的腹股沟淋巴结出现非精原细胞瘤“复发”，化疗后状况良好。
